Sentiment-Signal
33,8
Bearisch
Composite Score (0–100)
Insider (25%)
75.8
2 Insider, 1,8M $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 12.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☐ Item 5.02 Departure of Directors of Principal Officers; Election of Directors; Appointment |
| 20.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors of Principal Officers; Election of Directors; Appointment |
| 12.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment o |
| 17.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors of Principal Officers; Election of Directors; App |
| 09.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | reference this Item 2.02 of this report. Item 5.02 Departure of Directors of Principal Officers; Election of Directors |
| 15.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | m 8-K and is incorporated herein by reference. Item 5.02. Departure of Directors or Certain Officers; Election of Direct |
| 01.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors of Principal Officers; Election of Directors; Appointm |
| 05.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors of Principal Officers; Election of Directors; Appointment of Principal Officers. |
| 03.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors of Principal Officers; Election of Directors; Appointment of Principal Officers. |
| 14.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | press release concerning the matters disclosed in Item 5.02 above. The information furnished in this Item 7.01 will not |
| 21.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointmen |
| 20.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointmen |
| 07.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointmen |
Stammdaten
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Unternehmen & Branche
| Name | Orthofix Medical Inc. |
|---|---|
| Ticker | OFIX |
| CIK | 0000884624 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 473,9 Mio. USD |
| Beta | 0,82 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 822,312,000 | -92,192,000 | -2.33 | 850,647,000 | 450,037,000 |
| 2025-09-30 | 10-Q | 205,634,000 | -22,795,000 | -0.57 | 832,610,000 | 442,486,000 |
| 2025-06-30 | 10-Q | 203,121,000 | -14,081,000 | -0.36 | 837,157,000 | 458,347,000 |
| 2025-03-31 | 10-Q | 193,646,000 | -53,094,000 | -1.35 | 823,144,000 | 458,294,000 |
| 2024-12-31 | 10-K | 799,491,000 | -125,997,000 | -3.30 | 893,294,000 | 503,124,000 |
| 2024-09-30 | 10-Q | 196,606,000 | -27,388,000 | -0.71 | 867,872,000 | 525,924,000 |
| 2024-06-30 | 10-Q | 198,620,000 | -33,443,000 | -0.88 | 881,998,000 | 546,004,000 |
| 2024-03-31 | 10-Q | 188,608,000 | -36,020,000 | -0.95 | 906,050,000 | 570,315,000 |
| 2023-12-31 | 10-K | 746,641,000 | -151,395,000 | -4.12 | 925,315,000 | 598,730,000 |
| 2023-09-30 | 10-Q | 184,006,000 | -28,857,000 | -0.77 | 905,652,000 | 615,483,000 |
| 2023-06-30 | 10-Q | 187,016,000 | -39,426,000 | -1.07 | 901,287,000 | 639,985,000 |
| 2023-03-31 | 10-Q | 175,204,000 | -60,938,000 | -1.71 | 917,136,000 | 664,159,000 |
| 2022-12-31 | 10-K | 460,713,000 | -19,749,000 | -0.98 | 458,629,000 | 336,860,000 |
| 2022-09-30 | 10-Q | 113,996,000 | -10,716,000 | -0.53 | 449,660,000 | 333,539,000 |
| 2022-06-30 | 10-Q | 118,070,000 | 2,489,000 | 0.12 | 461,656,000 | 341,946,000 |
| 2022-03-31 | 10-Q | 106,418,000 | -4,460,000 | -0.22 | 461,993,000 | 335,575,000 |
| 2021-12-31 | 10-K | 464,479,000 | -38,379,000 | -1.95 | 476,623,000 | 336,934,000 |
| 2021-09-30 | 10-Q | 112,428,000 | -2,171,000 | 0.11 | 500,395,000 | 364,833,000 |
| 2021-06-30 | 10-Q | 121,394,000 | 2,420,000 | 0.12 | 502,010,000 | 362,284,000 |
| 2021-03-31 | 10-Q | 105,593,000 | -5,816,000 | -0.30 | 513,874,000 | 354,818,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Cedron Jorge Andres | Officer, CLO | Open Market Sale | -3,743 | 12.82 | -47,985.26 | -35,6% | |
| 2026-03-17 | Vitale Lucas | Officer, CP&BOO | Open Market Sale | -4,269 | 11.92 | -50,886.48 | -37,8% | |
| 2026-03-10 | CAPPS VICKIE L | Director | Open Market Purchase | 2,400 | 12.45 | 29,880.00 | +22,2% | |
| 2026-03-10 | CAPPS VICKIE L | Director | Open Market Purchase | 100 | 12.44 | 1,244.00 | +0,9% | |
| 2026-03-09 | CAPPS VICKIE L | Director | Open Market Purchase | 2,500 | 12.48 | 31,200.00 | +23,2% | |
| 2026-03-05 | Andrews Julie | Officer, CFO | Open Market Sale | -2,363 | 12.55 | -29,657.54 | -22,0% | |
| 2026-03-05 | McPherron Aviva | Officer, Pres, Global Ops & Qual | Open Market Sale | -1,263 | 12.55 | -15,851.66 | -11,8% | |
| 2026-03-05 | Calafiore Massimo | Director, Officer, President & CEO | Open Market Sale | -6,031 | 12.55 | -75,693.87 | -56,2% | |
| 2026-03-05 | Cedron Jorge Andres | Officer, CLO | Open Market Sale | -1,370 | 12.55 | -17,194.60 | -12,8% | |
| 2026-03-05 | REINHARDT MAX | Officer, President, Global Spine | Open Market Sale | -1,053 | 12.55 | -13,215.99 | -9,8% | |
| 2026-03-05 | Vitale Lucas | Officer, CP&BOO | Open Market Sale | -1,141 | 12.55 | -14,320.46 | -10,6% | |
| 2026-03-05 | Fisher Patrick | Officer, President, Global Limb Recon | Open Market Sale | -758 | 12.55 | -9,513.51 | -7,1% | |
| 2026-03-04 | Andrews Julie | Officer, CFO | Open Market Sale | -2,425 | 12.92 | -31,322.03 | -23,2% | |
| 2026-03-04 | REINHARDT MAX | Officer, President, Global Spine | Open Market Sale | -1,080 | 12.92 | -13,949.60 | -10,4% | |
| 2026-03-04 | McPherron Aviva | Officer, Pres, Global Ops & Qual | Open Market Sale | -1,296 | 12.92 | -16,739.52 | -12,4% | |
| 2026-03-04 | Fisher Patrick | Officer, President, Global Limb Recon | Open Market Sale | -778 | 12.92 | -10,048.88 | -7,5% | |
| 2026-03-04 | Calafiore Massimo | Director, Officer, President & CEO | Open Market Sale | -6,189 | 12.92 | -79,938.98 | -59,3% | |
| 2026-03-04 | Vitale Lucas | Officer, CP&BOO | Open Market Sale | -1,171 | 12.92 | -15,124.99 | -11,2% | |
| 2026-03-04 | Cedron Jorge Andres | Officer, CLO | Open Market Sale | -1,405 | 12.92 | -18,147.40 | -13,5% | |
| 2026-02-25 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 9,959 | 12.96 | 129,102.50 | +95,8% | |
| 2026-02-25 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 3,102 | 12.96 | 40,212.47 | +29,8% | |
| 2026-02-24 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 117,076 | 12.55 | 1,468,776.96 | +1089,9% | |
| 2026-02-24 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 7,721 | 12.55 | 96,863.81 | +71,9% | |
| 2026-01-16 | Andrews Julie | Officer, CFO | Open Market Sale | -4,873 | 14.38 | -70,073.74 | -52,0% | |
| 2026-01-12 | Calafiore Massimo | Director, Officer, President & CEO | Open Market Sale | -9,797 | 15.21 | -149,049.60 | -110,6% | |
| 2026-01-09 | Calafiore Massimo | Director, Officer, President & CEO | Open Market Sale | -9,600 | 15.82 | -151,905.60 | -112,7% | |
| 2025-08-18 | Fisher Patrick | Officer, President, Global Orthopedics | Open Market Sale | -1,996 | 14.21 | -28,363.16 | -21,0% | |
| 2025-07-02 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 1,250 | 11.11 | 13,881.25 | +10,3% | |
| 2025-06-18 | McPherron Aviva | Officer, Pres, Global Ops & Qual | Open Market Sale | -3,728 | 10.51 | -39,181.28 | -29,1% | |
| 2025-06-11 | REINHARDT MAX | Officer, President, Global Spine | Open Market Sale | -1,643 | 11.64 | -19,124.52 | -14,2% | |
| 2025-06-04 | Bazaar Alan Lee | Director | Open Market Purchase | 2,250 | 10.92 | 24,570.00 | +18,2% | |
| 2025-05-12 | Bazaar Alan Lee | Director | Open Market Purchase | 2,000 | 12.59 | 25,172.00 | +18,7% | |
| 2025-05-09 | Calafiore Massimo | Director, Officer, President & CEO | Open Market Purchase | 10,000 | 12.54 | 125,400.00 | +93,0% | |
| 2025-05-09 | Bazaar Alan Lee | Director | Open Market Purchase | 1,990 | 12.62 | 25,119.77 | +18,6% | |
| 2025-05-07 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 8,519 | 12.31 | 104,868.89 | +77,8% | |
| 2025-05-07 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 83,375 | 12.31 | 1,026,346.25 | +761,6% | |
| 2025-05-07 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 8,519 | 12.31 | 104,868.89 | +77,8% | |
| 2025-05-07 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 8,106 | 12.31 | 99,784.86 | +74,0% | |
| 2025-05-07 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 83,375 | 12.31 | 1,026,346.25 | +761,6% | |
| 2025-05-07 | Engine Capital Management, LP | 10% Owner | Open Market Purchase | 8,106 | 12.31 | 99,784.86 | +74,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.